Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes

Cardiovascular Research

Volumn 79, Issue 4, 2008, Pages 632-641

  Sun, Ying Gang ^a   Cao, Yin Xiang ^a   Wang, Wen Wei ^a   Ma, Shan Feng ^a   Yao, Tai ^a   Zhu, Yi Chun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Calcium; Ion channels; Myocytes

Indexed keywords

ADENOSINE TRIPHOSPHATE; CAFFEINE; CALCIUM CHANNEL L TYPE; CYCLIC AMP; HYDROGEN SULFIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE CELL; HEART REPOLARIZATION; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; WISTAR KYOTO RAT;

ACTION POTENTIALS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CELLS, CULTURED; CYCLIC AMP; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HYDROGEN SULFIDE; KATP CHANNELS; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PAPILLARY MUSCLES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SULFIDES; TIME FACTORS;

EID: 52449126689     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn140     Document Type: Article

References (38)

1. Moore PK, Bhatia M, Moochhala S. Hydrogen sulfide: from the smell of the past to the mediator of the future? Trends Pharmacol Sci 2003;24:609-611.
2. ATP channel opener. EMBO J 2001;20:6008-6016.
3. Shi YX, Chen Y, Zhu YZ, Huang GY, Moore PK, Huang SH et al. Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis and ROS production in SHR. Am J Physiol Heart Circ Physiol 2007;293:H2093-H2100.
4. Cai WJ, Wang MJ, Moore PK, Jin HM, Yao T, Zhu YC. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 2007;76:29-40.
5. Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 2006;316:670-678.
6. Zhu YZ, Wang ZJ, Ho P, Loke YY, Zhu YC, Huang SH et al. Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. J Appl Physiol 2007;102:261-268.
7. 2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 2004;313:362-368.
8. Xu M, Wu YM, Li Q, Wang FW, He RR. Electrophysiological effects of hydrogen sulfide on guinea pig papillary muscles in vitro. Acta Physiologica Sinica 2007;59:215-220.
9. Huxley HE. The mechanism of muscle contraction. Science 1969;164:1355-1366.
10. 2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 2004;110:2651-2657.
11. Wagner JA, Sax FL, Weisman HF. Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy. N Engl J Med 1989;320:755-761.
12. Wagner JA, Reynolds IJ, Weisman WF. Calcium antagonist receptors in cardiomyopathic hamster: selective increases in heart, muscle, and brain. Science 1986;232:515-518.
13. 2+ current downregulation in rat atrial myocytes during heart failure. Circ Res 2001;89:607-613.
14. Katz A. Calcium channel diversity in the cardiovascular system. J Am Coll Cardiol 1996;28:522-529.
15. Maurizio S, Amedeo L, Rodolfo T, Lucia V, Francesco A. Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats. Hypertension 2000;35:775-779.
16. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994;90:2786-2796.
17. Vos MA, Gorgels AP, Leunissen JD, Wellens HJ. Flunarizine allows differentiation between mechanisms of arrhythmias in the intact heart. Circulation 1990;81:343-349.
18. Pirzada A, Majid M. Acute hemodynamic effects of nifedipine in patients with ischemic heart disease. Circulation 1982;65:1114-1118.
19. Massion PB, Feron O, Dessy C, Balligand JL. Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 2003;93:388- 398.
20. Zhang ZH, Boutjdir M, El-Sherif N. Ketanserin inhibits depolarization-activated outward potassium current in rat ventricular myocytes. Circ Res 1994;75:711-721.
21. Lee KS, Tsien RW. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature 1983;302:790-794.
22. Liu S, Melchert RB, Kennedy RH. Inhibition of L-type calcium channel current in rat ventricular myocytes by terfenadine. Circ Res 1997;81:202-210.
23. k,slow currents. Cardiovasc Res 2004;62:509-520.
24. 2 metabolism in guinea pig ventricular cells. Am J Physiol Heart Circ Physiol 2002;282:757-765.
25. 2+ sparks in mouse ventricular myocytes. Am J Physiol Heart Circ Physiol 2000;278:666-669.
26. Bodo C, Markus F, Evi K, Christoph M, Anke N, Alexander S et al. Modulation of myocardial contractility by lysophosphatidic acid (LPA). J Mol Cell Cardiol 2003;35:71-80.
27. Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OH. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 1995;91:161-170.
28. Ndisang JF, Wang R. Mechanisms underlying selective regulation of blood pressure by heme oxygenase-1 in hypertension. Hypertension 2002;40:315-321.
29. ATP channel opener. EMBO J 2001;20:6008-6016.
30. Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 2005;19:1196-1198.
31. Yan H, Du JB, Tang CS. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 2004;313:22-27.
32. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997;237:527-531.
33. 2+ release and influx in human B lymphocytes. Cell Calcium 2001;29:149-160.
34. Rannou F, Sainte-Beuve C, Oliviero P. The effects of compensated cardiac hypertrophy on dihydropyridine and ryanodine recepters in rat, ferret, and guinea pig hearts. J Mol Cell Cardiol 1995;27:1225-1234.
35. i-transients in single ventricular myocytesisolated from terminally failing human hearts. Basic Res Cardiol 1992;87:235-243.
36. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 1996;16:1066-1071.
37. Rannou F, Sainte BC, Oliviero P et al. The effects of compensated cardiac hypertrophy on dihydropyridine and ryanodine recepters in rat, ferret, and guinea pig hearts. J Mol Cell Cardiol 1995;27:1225-1234.
38. ATP channel opener. EMBO Journal 2001;20:6008-6016.